j]h,g

J]h,g

Parkinson Study Group (Joseph H. Friedman first author). Low Dose Clozapine for The Treatment of Drug-Induced Psychosis In P

Nathan Wetzler, Marijn J.H. Heule and Warren A. Hunt (2014). DRAT-trim: Efficient Checking and Trimming Using Expressive Clausal Proofs. In Theory and Applications of Satisfiability Testing – SAT 2014, pp. 422-429. Lecture Notes in Computer Science 8561, Springer. [pdf]


j]h,g

Park, H.-S., and Yu, J.-H. 2012. Multi-Copy Genetic Screen in Aspergillus nidulans. Methods in Molecular Biology 944: 183-190. doi:10.1007/978-1-62703-122-6_13. Park, H-S., and Yu, J-H. 2012. Genetic control of asexual sporulation in filamentous fungi, Current Opinion in Microbiology, 15: 669-677. doi:10.1016/j.mib.2012.09.006 (Invited Review) Kwon, N-J., Park, H-S., Jung, S., Kim, S.C., and Yu, J-H. 2012. The putative guanine nucleotide exchange factor RicA mediates upstream signaling for growth and development in Aspergillus. Eukaryotic Cell 11: 1399-1412 Park, H-S., Ni, M., Jeong, K-C., Kim, Y-H., and Yu, J-H. 2012. The role, interaction and regulation of the velvet regulator VelB in Aspergillus nidulans, PLoS ONE  7(9): e45935. doi:10.1371/journal.pone.0045935 Park, H-S., Bayram, Ö, Braus, G.H., Kim, S-C., and Yu, J-H. 2012. Characterization of the velvet regulators in Aspergillus fumigatus. Molecular Microbiology. 86: 937-953 DOI: 10.1111/mmi.12032 Bayram, Ö.S., Bayram, Ö, Valerius, O., Park, H.-S., Irniger S., Gerke, J., Ni, M., Han, K.-H., Yu, J.-H., and Braus, G.H. 2010. LaeA control of velvet family regulatory proteins for light-dependent development and fungal cell-type specificity. PLoS GENETICS, 6(12):e1001226. Tao, L., and Yu, J.-H. 2011. AbaA and WetA govern distinct stages of Aspergillus fumigatus development. Microbiology-SGM, 157: 313 - 326. doi:10.1099/mic.0.044271-0 Yu, J.-H. 2010. Regulation of Development in Aspergillus nidulans and Aspergillus fumigatus. Mycobiology, 38: 229-237. Xiao, P., Shin, K.-S., Wang, T., and Yu, J.-H. 2010. Aspergillus fumigatus flbB encodes two basic leucine zipper domain (bZIP) proteins required for proper asexual development and gliotoxin production. Eukaryotic Cell, 9: 1711-1723. Kwon, N.-J., Shin, K.-S., and Yu, J-H. 2010. Characterization of the developmental regulator FlbE in Aspergillus fumigatus and Aspergillus nidulans. Fungal Genetics and Biology, 47: 981-993. Kwon, N.-J., Garzia, A., Espeso, E.A., Ugalde, U., and Yu, J-H. 2010. FlbC is a putative nuclear C2H2 transcription factor regulating development in Aspergillus nidulans. Molecular Microbiology 77: 1203-1219. Shin, K.-S., Kwon, N.-J., Park, H.-S., Kwon, G.-S., and Yu, J.-H. 2009. Differential roles of the ChiB chitinase in autolysis and cell death of Aspergillus nidulans. Eukaryotic Cell, 8:738-746. Bayram, Ö, Krappmann, S., Ni, M., Bok, J.-W., Helmstaedt, K., Valerius, O., Braus-Stromeyer, S., Kwon, N-J., Keller, N.P., Yu, J.-H., and Braus, G.H. 2008. The velvet complex coordinates light, fungal development and secondary metabolism. Science, 320: 1504-1506. Ni, M. and Yu, J.-H. 2007. A novel regulator couples sporogenesis and trehalose biogenesis in Aspergillus nidulans. PLoS ONE 2(10):e970 doi:10.1371/journal.pone.0000970. Mah, J.-H., and Yu, J.-H. 2006. Upstream and downstream regulation of asexual development in Aspergillus fumigatus. Eukaryotic Cell. 5: 1585-1595. Yu, J.-H. 2006. Heterotrimeric G protein signaling and RGSs in Aspergillus nidulans. Journal of Microbiology 44: 145-154.



فيديو j]h,g

JHG.Pasti Bisa (Official Audio)

مقالة عن j]h,g

Chou K, de Castillo Moro M, Friedman JH. Parkinsonian side effects of atypical antipsychotics in the elderly. Primary Care Psychiatry. In Press.

Murphy M, Friedman JH, Factor SA, Tetrud J. Atypical presentations of common disorders misdiagnosed as progressive supranuclear palsy (PSP). J Neurology. In press.

Scoggan KA, Friedman JH, Bulman DE. CACNA1A mutation in an EA-w patient responsive to acetazolamide and valproic acid. Can J Neurosci. In Press.

Borek L, Friedman JH. L-Dopa abuse in a patient with Parkinson's disease. Neurology. In Press

Chou K, Friedman JH. Symptoms of drug induced psychosis in Parkinson's disease. Clin Neuropharmacol. In Press.

Friedman JH, Treischmann ME, Myers RH, Fernandez HH. Monzygotic twins discordant for Huntington's disease after seven years. Arch Neurol 2005;62:995-997.

D'Abreu A, Friedman J, Coskun J. Non-movement herald symptoms of Machado Joseph Disease (SCA 3). Mov Disord. 2005;20:739-41

Friedman JH, Treischmann ME, Myers RH, Fernandez HH. Monzygotic twins discordant for Huntington's disease after seven years. Arch Neurol 2005;62:995-997.

Fernandez HH, Friedman JH, Lansang CM, Factor SA, et al. Diabetes mellitus among parkinsonian patients treated chronically with clozapine. Parkinsonism Rel Disord 2004;10:439-41. .

Fernandez HH, Trieschmann ME, Friedman JH. Aripiprazole for Drug-Induced Psychosis in Parkinson Disease: Preliminary Experience. Cln Neuropharmacol 2004;27(1):4-5.

Friedman JH, Fernandez HH, Trieschmann MM. Parkinsonism in a Nursing Home: Underrecognition. J Geriatr Psychiatry Neurol 2004;17(1):39-41.

Al-Yacoub M, Fernandez HH, Friedman JH. Hemiballism from a parietal stroke in a patient with Parkinson's disease. Mov Disord 2004;19:986-988.

Ready R, Friedman J, Grace J et al. Testosterone deficiency and fatigue in Parkinson's disease. J Neurol Neurosurg & Psychiatry. 2004;75:1323-26.

Stern MB, Marek K, Friedman JH, et al. Double-blind, Randomized, Controlled Trial of Rasagiline as Monotherapy in Early Parkinson's Disease Patients. Mov Disord 2004;19(8):916-923

Fernandez HH, Donnelly EM, Friedman JH. Long term outcome of clozapine use for psychosis in Parkinson's disease. Mov Disord 2004;19:831-3

Fernandez HH, Lannon MC, Trieschmann ME, Friedman JH. Botulinum toxin type B for gait freezing in Parkinson's disease. Med Sci Monit 2004 Jul;10(7): CR 282-4. Epub 2004. June 29

Fernandez HH, Friedman JH. Classification And Treatment of Tardive Syndromes. The Neurologist 2003;9:16-27.

Fernandez HH, Trieschmann ME, Burke MA, Jacques C, Friedman JH. Long-Term Outcome of Quetiapine Use for Psychosis Among Parkinsonian Patients. Movement Dis 2003;18:510-514.

Fernandez HH, Trieschmann ME, Friedman JH. Treatment of Psychosis in Parkinson's Disease. Safety Considerations. Drug Safety 2003:26:643-659.

Fernandez HH, Trieschmann ME, Friedman JH. Treatment of Psychosis in Parkinson's Disease. Safety Considerations. Drug Safety 2003:26:643-659.

Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003;60:1576-61.

Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003;60:119-1124.

Walker RH, Friedman JH, Wiener J, et al. A family with tau P301L mutation presenting with Parkinsonism. Parkinsonism & Related Disorders 2002; 9:121-123.

Zawacki TM., Grace J., Friedman JH., Sudarsky L. Executive and Emotional Dysfunction in Machado-Joseph Disease. Movement Disorders 2002;17:1004-1010.

Friedman, JH et al. Stroke induced by gamma knife pallidotomy: Autopsy result. Neurology 2002;58:1695-1697

Fernandez HH., Trieschmann ME, Burke, MA, Friedman JH. Quetiapine for Psychosis in Parkinson's Disease Versus Dementia With Lewy Bodies. J Clin Psychiatry 2002; 63: 513-515.

Friedman, JH. Presumed Rapid Eye Movement Sleep Behavior Disorder in Machado-Joseph Disease (Spinocerebellar Ataxia 3). Mov Disord 2002;17:1350-1353.

Friedman JH, Fernandez HH. Atypical antipsychotics in Parkinson-sensitive populations. J Geriatr Psychiatry Neurol. 2002;15(3):156-70

Breier A, Sutton VK, Feldman PD, Kadam DL, Ferchland I, Wright P, Friedman JH. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biol Psychiatry 2002;52:438-45.

Cahn-Weiner DA, Grace J, Ott BR, Fernandez, HH, Friedman, JH. Cognitive and Behavioral Features Discriminate Between Alzheimer's and Parkinson's Disease. Neuropsychiatry, Neurology, and Behavioral Neurology, 2002;15:79-87.

Breier A, Sutton VK, Feldman PD, Kadam DL, Ferchland I, Wright P, Friedman JH. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biol Psychiatry 2002;52:438-45.

Cahn-Weiner DA, Grace J, Ott BR, Fernandez, HH, Friedman, JH. Cognitive and Behavioral Features Discriminate Between Alzheimer's and Parkinson's Disease. Neuropsychiatry, Neurology, and Behavioral Neurology, 2002;15:79-87.

Brin, MF., Lyones, KE., Doucette, J., Adler, CH., Caviness, JN., Comella, CL., Dubinsky, RM., Friedman, JH. et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 2001;56:1523-1528.

Friedman, JH. Permanent Cerebellar Toxicity of Cytosine Arabinoside (Ara C) in a Young Woman. Mov Disord 2001; 16: 575-577

Goldstein S, Friedman JH, Marek K, et al. Hemiparkinsonism Due to a Midbrain Arteriovenous Malformation: Dopamine Transporter Imaging. Mov Disord 2001;16(2):350-375.

Fernandez, H., Krupp, B., Friedman, JH. The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up. Neurology 2001; 56:805-807.

Fernandez H., Rowena EJ., Tabamo,MD., David RR., Friedman JH. Predictors of Depressive Symptoms Among Spouse Caregivers in Parkinson's Disease. Movement Disorders 2001;16:1123-1125

Fernandez H., Friedman JH., Fischman, A., Noto, R., Lannon, MC. Is Altropane SPECT More Sensitive to FluoroDOPA PET for Detecting Early Parkinson's Disease? Altropane SPECT versus FluoroDOPA PET in Parkinson's disease. Med Sci Monit, 2001;7:2-6.

Friedman, JH, Fernandez HH. Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease. Clinical Neuropharmacology 2001 24;(2):120-121.

Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K, and the Parkinson Study Group. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12-week open label extension in the PSYCLOPS trial. Movement Disorders 2001 Jan: 16 (1): 135-139.

Friedman, JH, Friedman, H. Fatigue in Parkinson's Disease: A Nine-Year Follow-Up. Movement Disorders 2001;16:1120-1122

Fernandez H., Rowena EJ., Tabamo,MD., David RR., Friedman JH. Predictors of Depressive Symptoms Among Spouse Caregivers in Parkinson's Disease. Movement Disorders 2001;16:1123-1125

Friedman, JH, Friedman, H. Fatigue in Parkinson's Disease: A Nine-Year Follow-Up. Movement Disorders 2001;16:1120-1122

Fernandez H., Friedman JH., Fischman, A., Noto, R., Lannon, MC. Is Altropane SPECT More Sensitive to FluoroDOPA PET for Detecting Early Parkinson's Disease? Altropane SPECT versus FluoroDOPA PET in Parkinson's disease. Med Sci Monit, 2001;7:2-6.

Friedman, JH, Fernandez HH. Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease. Clinical Neuropharmacology 2001 24;(2):120-121.

Factor SA, Friedman JH, Lannon MC, Oakes D, Bourgeois K, and the Parkinson Study Group. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12-week open label extension in the PSYCLOPS trial. Movement Disorders 2001 Jan: 16 (1): 135-139.

Zawacki T, Friedman JH, Grace J, Shetty N. Cerebellar toxicity of cytosine arabinoside: Clinical and neuropsychological signs. Neurology 2000 (Clinical/Scientific Notes) 55; (8): 1234

Fernandez HH, Friedman, JH, Famiglietti EV. Probable Cornelia de Lange Syndrome With Progressive Parkinsonism and Dystonia. Movement Disorders 2000 (Clinical/Scientific Notes) 15;(4): 749-751

Tabamo REJ, Fernandez HH, Friedman JH, Simon DK. Young-Onset Parkinson's Disease: A Clinical Pathologic Description of Two Siblings. Movement Disorders 2000 (Clinical/Scientific Notes) 15;(4):744-746

Fernandez HH, Lannon MC, Friedman JH, Abbott BP. Clozapine Replacement by Quetiapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000 (Clinical/Scientific Notes) 15; (3):579-586

Fernandez HH, Lapane KL, Ott BR, Friedman, JH. Gender Differences in the Frequency and Treatment of Behavior Problems in Parkinson's Disease. Movement Disorders 2000; 15:(3) 490-496

Friedman JH, Factor SA. Atypical Antipsychotics in the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000; 15(2):201-211

Fernandez HH, Friedman JH, Grace J, Beason-Hazen, S. Donepezil for Huntington's Disease Movement Disorders 2000; 15: 173-175

Friedman JH, Fernandez HH. The Nonmotor Problems of Parkinson's Disease. The Neurologist 2000; 6: (1) 18-27

Fernandez HH, Lannon MC, Friedman JH, Abbott BP. Clozapine Replacement by Quetiapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000 (Clinical/Scientific Notes) 15; (3):579-586

Fernandez HH, Lapane KL, Ott BR, Friedman, JH. Gender Differences in the Frequency and Treatment of Behavior Problems in Parkinson's Disease. Movement Disorders 2000; 15:(3) 490-496

Friedman JH, Factor SA. Atypical Antipsychotics in the Treatment of Drug-Induced Psychosis in Parkinson's Disease. Movement Disorders 2000; 15(2):201-211

Friedman JH, Fernandez HH. The Nonmotor Problems of Parkinson's Disease. The Neurologist 2000; 6: (1) 18-27

Fernandez HH, Friedman JH, Grace J, Beason-Hazen, S. Donepezil for Huntington's Disease Movement Disorders 2000; 15: 173-175

Tabamo REJ, Fernandez HH, Friedman JH, Simon DK. Young-Onset Parkinson's Disease: A Clinical Pathologic Description of Two Siblings. Movement Disorders 2000 (Clinical/Scientific Notes) 15;(4):744-746

Fernandez HH, Friedman JH. Punding on L-DOPA. Mov Disorders 1999; 14:836-838.

Fernandez HH, Friedman JH. Atypical antipsychotics in movement disorder patients. CNS Drugs. 1999; 11(6):467-483.

Rosenfeld M, Friedman JH. Catatonia Responsive to Lorazepam.Mov Dis. 1999;14(1):161-162.

Lapane K, Fernandez HH, Friedman JH. And The SAGE Study Group. Prevalence, Clinical Characteristics, and Pharmacologic Treatment of Parkinson's Disease in Residents in Long-Term Care Facilities. Pharmacoepidemiology 1999; 19:1321-1327

Parkinson Study Group (Joseph H. Friedman first author). Low Dose Clozapine for The Treatment of Drug-Induced Psychosis In P

Source: https://vivo.brown.edu/display/johfried


مزيد من المعلومات حول j]h,g j]h,g

Leave a Replay

Submit Message